ACTIVE

APOTHEEK ANDRÉ DUMONT

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

132,4 k €

+109.8% YoY

Gross margin

544,7 k €

+4.7% YoY

Equity

415,6 k €

+1.8% YoY

Workforce

5,4 ETP

0.0% YoY

What does APOTHEEK ANDRÉ DUMONT do?

APOTHEEK ANDRÉ DUMONT is a Private limited company incorporated in 1978. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Maasmechelen. It employs on average 5,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0418.632.501

Incorporation

01/01/1978

Legal form

Private limited company

Registered office

Windmolenweg(B) 92
3631 Maasmechelen · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Average workforce

5,4 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	544,7 k €	+4.7%	520 k €	+26.7%	410,4 k €	-47.0%	774,6 k €	+37.5%	563,5 k €	+33.7%	421,4 k €	-7.4%	455 k €	-11.2%	512,6 k €	+51.9%	337,5 k €	+31.7%	256,3 k €	+24.1%	206,6 k €	+36.6%	151,3 k €	-24.8%	201,2 k €	-7.5%	217,5 k €	-8.9%	238,6 k €	+35.6%	176 k €	+60.5%	109,7 k €	-14.8%	128,8 k €
EBITDA	230,4 k €	+41.0%	163,5 k €	+20.2%	136 k €	-72.9%	502,4 k €	+71.8%	292,4 k €	+37.9%	212 k €	-16.8%	254,9 k €	-15.6%	301,9 k €	+122%	135,7 k €	+12.8%	120,3 k €	+2.1%	117,8 k €	+31.5%	89,5 k €	-21.3%	113,8 k €	-18.2%	139 k €	-23.4%	181,5 k €	+55.9%	116,5 k €	+10.5%	105,4 k €	-15.3%	124,3 k €
Operating result	183,3 k €	+57.0%	116,7 k €	+30.6%	89,4 k €	-81.4%	480,2 k €	+75.3%	274 k €	+45.0%	189 k €	-17.3%	228,4 k €	-18.9%	281,7 k €	+143%	116,1 k €	+23.3%	94,1 k €	+49.1%	63,1 k €	+10.1%	57,3 k €	+41.5%	40,5 k €	-34.1%	61,4 k €	-42.0%	105,9 k €	+125%	47,1 k €	+12.5%	41,8 k €	-26.2%	56,7 k €
Net result	132,4 k €	+110%	63,1 k €	+39.8%	45,2 k €	-87.1%	349,5 k €	+162%	133,5 k €	-25.2%	178,6 k €	-16.5%	213,8 k €	-21.8%	273,2 k €	+144%	111,9 k €	+162%	42,7 k €	+61.1%	26,5 k €	-37.9%	42,7 k €	+87.5%	22,8 k €	+106%	-352,3 k €	-474%	94,2 k €	+112%	44,5 k €	-11.8%	50,4 k €	+60.7%	31,4 k €
Balance sheet
Equity	415,6 k €	+1.8%	408,2 k €	+0.8%	405,1 k €	+0.0%	405 k €	+631%	55,4 k €	-93.5%	856,9 k €	+13.8%	753,3 k €	+1.9%	739,5 k €	+11.0%	666,3 k €	+1.8%	654,4 k €	+7.0%	611,6 k €	+4.5%	585,1 k €	+7.9%	542,4 k €	+4.4%	519,6 k €	-40.4%	871,9 k €	+6.0%	822,7 k €	+3.1%	798,2 k €	+6.7%	747,7 k €
Total assets	1,7 M €	+0.1%	1,7 M €	-0.1%	1,7 M €	+1.0%	1,7 M €	+42.9%	1,2 M €	-43.8%	2,1 M €	-8.9%	2,3 M €	+5.4%	2,2 M €	+3.8%	2,1 M €	+1.8%	2,1 M €	-4.0%	2,1 M €	+23.1%	1,7 M €	-1.7%	1,8 M €	+3.4%	1,7 M €	-20.2%	2,1 M €	+19.6%	1,8 M €	+7.0%	1,7 M €	-3.9%	1,7 M €
Cash	70,8 k €	-11.7%	80,2 k €	-43.1%	140,9 k €	+10.7%	127,3 k €	+559%	19,3 k €	-20.9%	24,4 k €	-81.0%	128,7 k €	+69.3%	76 k €	+11.0%	68,5 k €	-3.5%	71 k €	+104%	34,8 k €	+83.3%	19 k €	+182%	6,7 k €	-67.8%	20,9 k €	-31.1%	30,3 k €	+13.9%	26,6 k €	+18.7%	22,4 k €	-5.9%	23,8 k €
Debts	1,3 M €	-0.4%	1,3 M €	-0.4%	1,3 M €	+1.3%	1,3 M €	+13.8%	1,1 M €	-9.3%	1,2 M €	-20.0%	1,5 M €	+7.3%	1,4 M €	+0.4%	1,4 M €	+1.8%	1,4 M €	-8.3%	1,5 M €	+32.5%	1,2 M €	-5.9%	1,2 M €	+3.0%	1,2 M €	-6.4%	1,3 M €	+31.5%	970,8 k €	+10.2%	881 k €	-11.8%	999,1 k €
Other
Workforce	5,4 ETP	0.0%	5,4 ETP	+25.6%	4,3 ETP	-8.5%	4,7 ETP	+4.4%	4,5 ETP	+12.5%	4,0 ETP	0.0%	4,0 ETP	-7.0%	4,3 ETP	0.0%	4,3 ETP	+26.5%	3,4 ETP	+47.8%	2,3 ETP	+53.3%	1,5 ETP	-46.4%	2,8 ETP	+40.0%	2,0 ETP	-9.1%	2,2 ETP	+46.7%	1,5 ETP		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 14 ended

Active mandates

INTER FARMA INVEST

Director · since 05 juin 2023 · 0438.493.250

Represented by CROUX JACOBUS

Active

PHICRO

Director · since 05 juin 2023 · 0821.790.532

Represented by CROUX PHILIPPE

Active

Ended mandates

INTER FARMA INVEST

Director · since 05 juin 2023 · 0438.493.250

Represented by CROUX JACOBUS

Ended

PHICRO

Director · since 05 juin 2023 · 0821.790.532

Represented by CROUX PHILIPPE

Ended

BIPHAR cvba

Director · since 06 décembre 2019 · 0892.878.565

Represented by CROUX PHILIPPE

Ended

Annick

Manager · since 29 juillet 2010 · 0827.045.853

Represented by Jacobus CROUX

Ended

At this address

Other companies at this address

Company	CBE no.
SACRO● Active	0893.358.023

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	15/05/2025	11/06/2024	17/08/2023	14/04/2022	13/07/2021
General meeting	26/06/2026	06/05/2025	04/06/2024	30/06/2023	31/03/2022	01/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	29/06/2026	Dutch	PDF
Abridged model	31/12/2024	06/05/2025	15/05/2025	Dutch	PDF
Abridged model	31/12/2023	04/06/2024	11/06/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	17/08/2023	Dutch	PDF
Abridged model	31/12/2021	31/03/2022	14/04/2022	Dutch	PDF
Abridged model	31/12/2020	01/06/2021	13/07/2021	Dutch	PDF
Abridged model	31/12/2019	12/06/2020	03/07/2020	Dutch	PDF
Abridged model	31/12/2018	29/06/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	29/06/2018	28/08/2018	Dutch	PDF
Abridged model	31/12/2016	16/06/2017	23/08/2017	Dutch	PDF
Abridged model	31/12/2015	29/04/2016	19/08/2016	Dutch	PDF
Abridged model	31/12/2014	24/04/2015	26/08/2015	Dutch	PDF
Abridged model	31/12/2013	25/04/2014	26/08/2014	Dutch	PDF
Abridged model	31/12/2012	26/04/2013	20/08/2013	Dutch	PDF
Abridged model	31/12/2011	27/04/2012	03/07/2012	Dutch	PDF
Abridged model	31/12/2010	29/04/2011	22/08/2011	Dutch	PDF
Abridged model	31/12/2009	25/06/2010	18/08/2010	Dutch	PDF
Abridged model	31/12/2008	26/06/2009	30/07/2009	Dutch	PDF
Abridged model	31/12/2007	27/06/2008	28/07/2008	Dutch	PDF
Abridged model	31/12/2006	29/06/2007	14/08/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 14 ended

Active mandates

INTER FARMA INVEST

Director · since 05 juin 2023 · 0438.493.250

Represented by CROUX JACOBUS

Active

PHICRO

Director · since 05 juin 2023 · 0821.790.532

Represented by CROUX PHILIPPE

Active

Ended mandates

INTER FARMA INVEST

Director · since 05 juin 2023 · 0438.493.250

Represented by CROUX JACOBUS

Ended

PHICRO

Director · since 05 juin 2023 · 0821.790.532

Represented by CROUX PHILIPPE

Ended

BIPHAR cvba

Director · since 06 décembre 2019 · 0892.878.565

Represented by CROUX PHILIPPE

Ended

Annick

Manager · since 29 juillet 2010 · 0827.045.853

Represented by Jacobus CROUX

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/06/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Restructuring23/12/2021
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
PDF
Mandates03/02/2020
ONTSLAGEN - BENOEMINGEN
PDF
Registered office31/05/2016
MAATSCHAPPELIJKE ZETEL
PDF
Registered office21/01/2014
BENAMING - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates23/03/2011
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/09/2010
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/08/2008
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025132,4 k €↑
2024
Annual accounts 202463,1 k €↑
2023
Annual accounts 202345,2 k €↓
2022
Annual accounts 2022349,5 k €↑
2021
Annual accounts 2021133,5 k €↓
2018
Annual accounts 2018178,6 k €↓
2017
Annual accounts 2017213,8 k €↓
2016
Annual accounts 2016273,2 k €↑
2015
Annual accounts 2015111,9 k €↑
2014
Annual accounts 201442,7 k €↑
2013
Annual accounts 201326,5 k €↓
2013
Name changeAPOTHEEK ANDRE DUMONT
2012
Annual accounts 201242,7 k €↑
2011
Annual accounts 201122,8 k €↑
2010
Annual accounts 2010-352,3 k €↓
2009
Annual accounts 200994,2 k €↑
2008
Annual accounts 200844,5 k €↓
2007
Annual accounts 200750,4 k €↑
2006
Annual accounts 200631,4 k €
2006
Name changeFARMAKA
01/01/1978
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

APOTHEEK ANDRÉ DUMONT

Overview

What does APOTHEEK ANDRÉ DUMONT do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline